HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William K Oh Selected Research

VA 061 (VA061)

9/2007Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy.
9/2006Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.
10/2005Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
9/2004Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
7/2003Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William K Oh Research Topics

Disease

134Prostatic Neoplasms (Prostate Cancer)
05/2022 - 02/2002
78Neoplasms (Cancer)
07/2022 - 01/2002
24Neoplasm Metastasis (Metastasis)
01/2021 - 08/2003
19Carcinoma (Carcinomatosis)
01/2022 - 02/2002
13Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 01/2002
9Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 07/2015
9Disease Progression
01/2015 - 10/2004
5Febrile Neutropenia
12/2015 - 03/2005
5Thromboembolism
12/2012 - 09/2002
4COVID-19
06/2022 - 01/2021
4Inflammation (Inflammations)
01/2021 - 05/2006
4Adenocarcinoma
09/2020 - 11/2011
4Carcinogenesis
11/2018 - 02/2011
4Melanoma (Melanoma, Malignant)
01/2018 - 06/2014
4Neutropenia
11/2016 - 12/2003
4Fatigue
12/2011 - 03/2005
47 Hereditary Prostate Cancer
12/2011 - 05/2009
3Chronic Renal Insufficiency
01/2021 - 03/2012
3Colonic Neoplasms (Colon Cancer)
11/2016 - 06/2011
2Breast Neoplasms (Breast Cancer)
04/2022 - 09/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2012
2Colitis
01/2018 - 11/2006
2Leukopenia
03/2016 - 02/2008
2Urologic Neoplasms (Urological Cancer)
06/2015 - 11/2012

Drug/Important Bio-Agent (IBA)

39Hormones (Hormone)IBA
04/2022 - 05/2003
38AndrogensIBA
01/2022 - 02/2002
34Prostate-Specific Antigen (Semenogelase)IBA
05/2022 - 02/2002
23Docetaxel (Taxotere)FDA Link
01/2022 - 12/2003
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2011
16Androgen Receptors (Androgen Receptor)IBA
05/2022 - 05/2008
16Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2004
10Immune Checkpoint InhibitorsIBA
07/2022 - 01/2018
9Testosterone (Sustanon)FDA Link
05/2022 - 07/2003
9Biological ProductsIBA
01/2021 - 10/2004
9Carboplatin (JM8)FDA LinkGeneric
09/2017 - 12/2003
8Pharmaceutical PreparationsIBA
05/2022 - 10/2005
8RNA (Ribonucleic Acid)IBA
01/2022 - 01/2006
7enzalutamideIBA
06/2022 - 05/2012
7PlatinumIBA
10/2020 - 02/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2017 - 02/2004
6taxaneIBA
12/2011 - 06/2005
6Estrogens (Estrogen)FDA Link
12/2011 - 01/2002
5abirateroneIBA
01/2022 - 05/2012
5Hemoglobins (Hemoglobin)IBA
11/2018 - 12/2009
5VA 061 (VA061)IBA
09/2007 - 07/2003
5herbal preparation PC-SPESIBA
09/2004 - 02/2002
4Androgen Antagonists (Antiandrogens)IBA
06/2022 - 10/2005
4LigandsIBA
01/2022 - 03/2011
4AntigensIBA
01/2022 - 02/2002
4EverolimusFDA Link
01/2022 - 12/2012
4Alkaline PhosphataseIBA
11/2018 - 12/2007
4GemcitabineFDA Link
01/2018 - 09/2004
4Tissue Inhibitor of Metalloproteinase-1IBA
05/2015 - 02/2011
4Angiogenesis InhibitorsIBA
01/2014 - 08/2009
4Bevacizumab (Avastin)FDA Link
10/2012 - 05/2010
4Ketoconazole (Nizoral)FDA LinkGeneric
05/2010 - 09/2006
4EstramustineFDA Link
03/2007 - 12/2003
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2004
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2008
3CytokinesIBA
01/2022 - 09/2012
3Opioid Analgesics (Opioids)IBA
11/2018 - 11/2006
3AlbuminsIBA
11/2018 - 06/2017
3Phenobarbital (Luminal)FDA Link
11/2018 - 02/2009
3tremelimumabIBA
01/2018 - 06/2014
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2016 - 12/2003
3Proteins (Proteins, Gene)FDA Link
05/2015 - 03/2011
3Prednisone (Sone)FDA LinkGeneric
04/2015 - 03/2009
3Taxoids (Taxanes)IBA
05/2013 - 06/2006
3Sunitinib (Sutent)FDA Link
11/2012 - 05/2010
3Sorafenib (BAY 43-9006)FDA Link
11/2012 - 05/2010
3SteroidsIBA
12/2011 - 09/2006
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2010 - 09/2002
3Diethylstilbestrol (Stilbestrol)FDA Link
06/2007 - 09/2002
2Aromatase InhibitorsIBA
04/2022 - 11/2002
2Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 11/2019
2cyclopropapyrroloindoleIBA
01/2020 - 11/2019
2MicroRNAs (MicroRNA)IBA
11/2018 - 07/2009
2Metformin (Glucophage)FDA LinkGeneric
11/2017 - 10/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 12/2015
2ParaffinIBA
11/2016 - 08/2014
2Monoclonal AntibodiesIBA
11/2016 - 09/2012
2Formaldehyde (Formol)FDA Link
11/2016 - 08/2014
2MTOR InhibitorsIBA
09/2014 - 02/2014
2TOR Serine-Threonine KinasesIBA
09/2014 - 12/2012
2insulin receptor-related receptor (IRR)IBA
09/2014 - 02/2014
2Matrix Metalloproteinases (MMPs)IBA
06/2014 - 02/2011
2cabazitaxelFDA Link
06/2014 - 01/2011
2bicalutamide (Casodex)FDA LinkGeneric
12/2012 - 06/2006
2CreatinineIBA
03/2012 - 06/2011

Therapy/Procedure

95Therapeutics
06/2022 - 02/2002
57Drug Therapy (Chemotherapy)
10/2020 - 05/2003
55Castration
05/2022 - 07/2003
9Radiotherapy
01/2022 - 06/2003
9Prostatectomy (Retropubic Prostatectomy)
11/2010 - 05/2003
7Neoadjuvant Therapy
11/2017 - 05/2003
5Cystectomy
11/2017 - 07/2015
4Immunotherapy
11/2019 - 01/2016
3Adjuvant Chemotherapy
03/2016 - 12/2003
3Combination Drug Therapy (Combination Chemotherapy)
01/2014 - 06/2011
3Nephrectomy
12/2013 - 10/2007